Oxford Cannabinoid Technologies Holdings (FRA:0CB) Capex-to-Revenue : 0.00 (As of Oct. 2023)

Oxford Cannabinoid Technologies Holdings Capex-to-Revenue Chart

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
	May19	Nov19	May20	Nov20	May21	Nov21	Oct22	Apr23	Oct23
Capex-to-Revenue	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's Capex-to-Revenue

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford Cannabinoid Technologies Holdings's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's Capex-to-Revenue falls into.

Oxford Cannabinoid Technologies Holdings Capex-to-Revenue Calculation

Oxford Cannabinoid Technologies Holdings's Capex-to-Revenue for the fiscal year that ended in Apr. 2023 is calculated as

Oxford Cannabinoid Technologies Holdings's Capex-to-Revenue for the quarter that ended in Oct. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford Cannabinoid Technologies Holdings  (FRA:0CB) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Oxford Cannabinoid Technologies Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description